<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nguyen TTM</submitter><funding>National Research Foundation (KR)</funding><funding>National Research Foundation</funding><pagination>42</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9903620</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>42(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Clear cell renal cell carcinoma (ccRCC), with its hallmark phenotype of high cytosolic lipid content, is considered a metabolic cancer. Despite the implication of this lipid-rich phenotype in ccRCC tumorigenesis, the roles and regulators of de novo lipid synthesis (DNL) in ccRCC remain largely unexplained.&lt;h4>Methods&lt;/h4>Our bioinformatic screening focused on ccRCC-lipid phenotypes identified glutathione peroxidase 8 (GPX8), as a clinically relevant upstream regulator of DNL. GPX8 genetic silencing was performed with CRISPR-Cas9 or shRNA in ccRCC cell lines to dissect its roles. Untargeted metabolomics, RNA-seq analyses, and other biochemical assays (e.g., lipid droplets staining, fatty acid uptake, cell proliferation, xenograft, etc.) were carried out to investigate the</pubmed_abstract><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pubmed_title>GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.</pubmed_title><pmcid>PMC9903620</pmcid><funding_grant_id>NRF-2020R1I1A1A01073124</funding_grant_id><funding_grant_id>NRF-2018R1A3B1052328</funding_grant_id><pubmed_authors>Mai VH</pubmed_authors><pubmed_authors>Kim JM</pubmed_authors><pubmed_authors>An YJ</pubmed_authors><pubmed_authors>Nguyen TH</pubmed_authors><pubmed_authors>Kang S</pubmed_authors><pubmed_authors>Kim HS</pubmed_authors><pubmed_authors>Jung CR</pubmed_authors><pubmed_authors>Dao TTP</pubmed_authors><pubmed_authors>Seo M</pubmed_authors><pubmed_authors>Park S</pubmed_authors><pubmed_authors>Nguyen TTM</pubmed_authors><pubmed_authors>Moon Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.</name><description>&lt;h4>Background&lt;/h4>Clear cell renal cell carcinoma (ccRCC), with its hallmark phenotype of high cytosolic lipid content, is considered a metabolic cancer. Despite the implication of this lipid-rich phenotype in ccRCC tumorigenesis, the roles and regulators of de novo lipid synthesis (DNL) in ccRCC remain largely unexplained.&lt;h4>Methods&lt;/h4>Our bioinformatic screening focused on ccRCC-lipid phenotypes identified glutathione peroxidase 8 (GPX8), as a clinically relevant upstream regulator of DNL. GPX8 genetic silencing was performed with CRISPR-Cas9 or shRNA in ccRCC cell lines to dissect its roles. Untargeted metabolomics, RNA-seq analyses, and other biochemical assays (e.g., lipid droplets staining, fatty acid uptake, cell proliferation, xenograft, etc.) were carried out to investigate the</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-05-29T19:43:41.846Z</modification><creation>2025-04-04T12:55:55.586Z</creation></dates><accession>S-EPMC9903620</accession><cross_references><pubmed>36750850</pubmed><doi>10.1186/s13046-023-02607-2</doi></cross_references></HashMap>